{"id":80729,"date":"2023-11-04T18:48:47","date_gmt":"2023-11-04T22:48:47","guid":{"rendered":"https:\/\/ifintechworld.com\/uncategorized\/gsk-invests-20-million-in-23andme-for-dna-data-access-and-analysis\/"},"modified":"2023-11-04T18:48:51","modified_gmt":"2023-11-04T22:48:51","slug":"gsk-invests-20-million-in-23andme-for-dna-data-access-and-analysis","status":"publish","type":"post","link":"https:\/\/ifintechworld.com\/?p=80729","title":{"rendered":"GSK invests $20 million in 23andMe for DNA data access and analysis"},"content":{"rendered":"
\n
\n

\u00a9 Reuters. <\/span>
\n<\/i>\n<\/div>\n

Pharmaceutical giant GSK Plc has announced an investment of $20 million in 23andMe Holding Co., marking an extension of their five-year collaboration. The investment grants GSK a year’s access to 23andMe\u2019s comprehensive consumer DNA data, which includes anonymized genetic information from roughly 80% of customers who have consented to share their data for research purposes. In addition to providing the data, 23andMe will also offer data analysis services to GSK.<\/p>\n

The DNA collected by 23andMe through its testing kits, which deliver ancestral and health information to customers, is considered a crucial resource for scientific research. With a database of over 14 million customers, only Ancestry.com and the Chinese government surpass 23andMe.<\/p>\n

GSK plans to utilize this extensive genetic data to uncover disease-related genetic pathways, with the goal of accelerating the traditionally lengthy drug development process. A significant achievement of the GSK-23andMe partnership is a potential cancer drug that targets CD96, an immune response-modulating protein. This drug reached clinical trials within four years, a substantial reduction from the industry average of seven years. The collaboration has also identified over 50 new potential drug targets.<\/p>\n

Under the revised terms of the agreement, GSK will retain exclusive ownership of any discoveries made using the 23andMe data. However, in a departure from their previous joint venture arrangement, 23andMe is set to earn royalties on some projects.<\/p>\n

InvestingPro Insights<\/h2>\n

In light of GSK’s recent investment and partnership with 23andMe, it’s beneficial to consider some key InvestingPro Tips and data. GSK, a prominent player in the pharmaceutical industry, has been profitable over the last twelve months and operates with a high return on assets, as per InvestingPro Tips. This profitability and operational efficiency may be advantageous in their partnership with 23andMe.<\/p>\n

Analyzing InvestingPro data, GSK’s market cap stands at a substantial $69.86B. The company has a P\/E ratio of 9.27, indicating a potentially undervalued stock. The company’s revenue growth for Q3 2023 was 2.16%, and it has a strong gross profit margin of 72.14% for the same period.<\/p>\n

InvestingPro also highlights that GSK has maintained dividend payments for 23 consecutive years, offering a dividend yield of 3.93% as of 2023. This consistent return to shareholders may be an attractive aspect for potential investors.<\/p>\n

For those interested in further insights and tips, InvestingPro offers a wealth of additional information, with 14 tips available specifically for GSK.<\/p>\n

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.<\/em><\/p>\n<\/div>\n

Read the full article here<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"

\u00a9 Reuters. Pharmaceutical giant GSK Plc has announced an investment of $20 million in 23andMe Holding Co., marking an extension of their five-year collaboration. The investment grants GSK a year’s access to 23andMe\u2019s comprehensive consumer DNA data, which includes anonymized genetic information from roughly 80% of customers who have consented to share their data for […]<\/p>\n","protected":false},"author":1,"featured_media":7482,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"video","meta":{"footnotes":""},"categories":[1],"tags":[83],"class_list":["post-80729","post","type-post","status-publish","format-video","has-post-thumbnail","hentry","category-uncategorized","tag-featured","post_format-post-format-video"],"yoast_head":"\nGSK invests $20 million in 23andMe for DNA data access and analysis | iFintechWorld<\/title>\n<meta name=\"description\" content=\"\u00a9 Reuters. Pharmaceutical giant GSK Plc has announced an investment of $20 million in 23andMe Holding Co., marking an extension of their five-year\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/ifintechworld.com\/?p=80729\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"GSK invests $20 million in 23andMe for DNA data access and analysis | iFintechWorld\" \/>\n<meta property=\"og:description\" content=\"\u00a9 Reuters. Pharmaceutical giant GSK Plc has announced an investment of $20 million in 23andMe Holding Co., marking an extension of their five-year\" \/>\n<meta property=\"og:url\" content=\"https:\/\/ifintechworld.com\/?p=80729\" \/>\n<meta property=\"og:site_name\" content=\"iFintechWorld\" \/>\n<meta property=\"article:published_time\" content=\"2023-11-04T22:48:47+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2023-11-04T22:48:51+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/ifintechworld.com\/wp-content\/uploads\/2023\/05\/LYNXMPEC0409P_L.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"800\" \/>\n\t<meta property=\"og:image:height\" content=\"533\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"News Room\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"News Room\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/ifintechworld.com\/?p=80729#article\",\"isPartOf\":{\"@id\":\"https:\/\/ifintechworld.com\/?p=80729\"},\"author\":{\"name\":\"News Room\",\"@id\":\"https:\/\/ifintechworld.com\/#\/schema\/person\/6224724fd4116361255b179dc5c70b61\"},\"headline\":\"GSK invests $20 million in 23andMe for DNA data access and analysis\",\"datePublished\":\"2023-11-04T22:48:47+00:00\",\"dateModified\":\"2023-11-04T22:48:51+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/ifintechworld.com\/?p=80729\"},\"wordCount\":425,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\/\/ifintechworld.com\/#organization\"},\"keywords\":[\"Featured\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/ifintechworld.com\/?p=80729#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/ifintechworld.com\/?p=80729\",\"url\":\"https:\/\/ifintechworld.com\/?p=80729\",\"name\":\"GSK invests $20 million in 23andMe for DNA data access and analysis | iFintechWorld\",\"isPartOf\":{\"@id\":\"https:\/\/ifintechworld.com\/#website\"},\"datePublished\":\"2023-11-04T22:48:47+00:00\",\"dateModified\":\"2023-11-04T22:48:51+00:00\",\"description\":\"\u00a9 Reuters. Pharmaceutical giant GSK Plc has announced an investment of $20 million in 23andMe Holding Co., marking an extension of their five-year\",\"breadcrumb\":{\"@id\":\"https:\/\/ifintechworld.com\/?p=80729#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/ifintechworld.com\/?p=80729\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/ifintechworld.com\/?p=80729#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/ifintechworld.com\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"GSK invests $20 million in 23andMe for DNA data access and analysis\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/ifintechworld.com\/#website\",\"url\":\"https:\/\/ifintechworld.com\/\",\"name\":\"Repay Down\",\"description\":\"Latest Personal Finance News, Tips and Updates\",\"publisher\":{\"@id\":\"https:\/\/ifintechworld.com\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/ifintechworld.com\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/ifintechworld.com\/#organization\",\"name\":\"Repay Down\",\"url\":\"https:\/\/ifintechworld.com\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/ifintechworld.com\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/ifintechworld.com\/wp-content\/uploads\/2023\/04\/rep-logo-dark.png\",\"contentUrl\":\"https:\/\/ifintechworld.com\/wp-content\/uploads\/2023\/04\/rep-logo-dark.png\",\"width\":558,\"height\":90,\"caption\":\"Repay Down\"},\"image\":{\"@id\":\"https:\/\/ifintechworld.com\/#\/schema\/logo\/image\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\/\/ifintechworld.com\/#\/schema\/person\/6224724fd4116361255b179dc5c70b61\",\"name\":\"News Room\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/ifintechworld.com\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/ifintechworld.com\/wp-content\/uploads\/2023\/04\/avatar_user_1_1682606986-96x96.png\",\"contentUrl\":\"https:\/\/ifintechworld.com\/wp-content\/uploads\/2023\/04\/avatar_user_1_1682606986-96x96.png\",\"caption\":\"News Room\"},\"sameAs\":[\"https:\/\/ifintechworld.com\"],\"url\":\"https:\/\/ifintechworld.com\/?author=1\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"GSK invests $20 million in 23andMe for DNA data access and analysis | iFintechWorld","description":"\u00a9 Reuters. Pharmaceutical giant GSK Plc has announced an investment of $20 million in 23andMe Holding Co., marking an extension of their five-year","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/ifintechworld.com\/?p=80729","og_locale":"en_US","og_type":"article","og_title":"GSK invests $20 million in 23andMe for DNA data access and analysis | iFintechWorld","og_description":"\u00a9 Reuters. Pharmaceutical giant GSK Plc has announced an investment of $20 million in 23andMe Holding Co., marking an extension of their five-year","og_url":"https:\/\/ifintechworld.com\/?p=80729","og_site_name":"iFintechWorld","article_published_time":"2023-11-04T22:48:47+00:00","article_modified_time":"2023-11-04T22:48:51+00:00","og_image":[{"width":800,"height":533,"url":"https:\/\/ifintechworld.com\/wp-content\/uploads\/2023\/05\/LYNXMPEC0409P_L.jpg","type":"image\/jpeg"}],"author":"News Room","twitter_card":"summary_large_image","twitter_misc":{"Written by":"News Room","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/ifintechworld.com\/?p=80729#article","isPartOf":{"@id":"https:\/\/ifintechworld.com\/?p=80729"},"author":{"name":"News Room","@id":"https:\/\/ifintechworld.com\/#\/schema\/person\/6224724fd4116361255b179dc5c70b61"},"headline":"GSK invests $20 million in 23andMe for DNA data access and analysis","datePublished":"2023-11-04T22:48:47+00:00","dateModified":"2023-11-04T22:48:51+00:00","mainEntityOfPage":{"@id":"https:\/\/ifintechworld.com\/?p=80729"},"wordCount":425,"commentCount":0,"publisher":{"@id":"https:\/\/ifintechworld.com\/#organization"},"keywords":["Featured"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/ifintechworld.com\/?p=80729#respond"]}]},{"@type":"WebPage","@id":"https:\/\/ifintechworld.com\/?p=80729","url":"https:\/\/ifintechworld.com\/?p=80729","name":"GSK invests $20 million in 23andMe for DNA data access and analysis | iFintechWorld","isPartOf":{"@id":"https:\/\/ifintechworld.com\/#website"},"datePublished":"2023-11-04T22:48:47+00:00","dateModified":"2023-11-04T22:48:51+00:00","description":"\u00a9 Reuters. Pharmaceutical giant GSK Plc has announced an investment of $20 million in 23andMe Holding Co., marking an extension of their five-year","breadcrumb":{"@id":"https:\/\/ifintechworld.com\/?p=80729#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/ifintechworld.com\/?p=80729"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/ifintechworld.com\/?p=80729#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/ifintechworld.com\/"},{"@type":"ListItem","position":2,"name":"GSK invests $20 million in 23andMe for DNA data access and analysis"}]},{"@type":"WebSite","@id":"https:\/\/ifintechworld.com\/#website","url":"https:\/\/ifintechworld.com\/","name":"Repay Down","description":"Latest Personal Finance News, Tips and Updates","publisher":{"@id":"https:\/\/ifintechworld.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/ifintechworld.com\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/ifintechworld.com\/#organization","name":"Repay Down","url":"https:\/\/ifintechworld.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/ifintechworld.com\/#\/schema\/logo\/image\/","url":"https:\/\/ifintechworld.com\/wp-content\/uploads\/2023\/04\/rep-logo-dark.png","contentUrl":"https:\/\/ifintechworld.com\/wp-content\/uploads\/2023\/04\/rep-logo-dark.png","width":558,"height":90,"caption":"Repay Down"},"image":{"@id":"https:\/\/ifintechworld.com\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/ifintechworld.com\/#\/schema\/person\/6224724fd4116361255b179dc5c70b61","name":"News Room","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/ifintechworld.com\/#\/schema\/person\/image\/","url":"https:\/\/ifintechworld.com\/wp-content\/uploads\/2023\/04\/avatar_user_1_1682606986-96x96.png","contentUrl":"https:\/\/ifintechworld.com\/wp-content\/uploads\/2023\/04\/avatar_user_1_1682606986-96x96.png","caption":"News Room"},"sameAs":["https:\/\/ifintechworld.com"],"url":"https:\/\/ifintechworld.com\/?author=1"}]}},"amp_enabled":true,"_links":{"self":[{"href":"https:\/\/ifintechworld.com\/index.php?rest_route=\/wp\/v2\/posts\/80729","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/ifintechworld.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/ifintechworld.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/ifintechworld.com\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/ifintechworld.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=80729"}],"version-history":[{"count":1,"href":"https:\/\/ifintechworld.com\/index.php?rest_route=\/wp\/v2\/posts\/80729\/revisions"}],"predecessor-version":[{"id":80730,"href":"https:\/\/ifintechworld.com\/index.php?rest_route=\/wp\/v2\/posts\/80729\/revisions\/80730"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/ifintechworld.com\/index.php?rest_route=\/wp\/v2\/media\/7482"}],"wp:attachment":[{"href":"https:\/\/ifintechworld.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=80729"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/ifintechworld.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=80729"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/ifintechworld.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=80729"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}